Dermata Therapeutics Inc
NASDAQ:DRMA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Dermata Therapeutics Inc
NASDAQ:DRMA
|
US |
|
Maxlinear Inc
NASDAQ:MXL
|
US |
|
Larsen and Toubro Ltd
F:LTO
|
IN |
|
Woodside Energy Group Ltd
ASX:WDS
|
AU |
|
Eternal Ltd
NSE:ETERNAL
|
IN |
|
Foxconn Industrial Internet Co Ltd
SSE:601138
|
CN |
|
B
|
Banco de Credito e Inversiones
SGO:BCI
|
CL |
|
E
|
EVI Industries Inc
AMEX:EVI
|
US |
|
Cross Country Healthcare Inc
NASDAQ:CCRN
|
US |
|
Primerica Inc
NYSE:PRI
|
US |
|
Columbus McKinnon Corp
NASDAQ:CMCO
|
US |
|
HCL Technologies Ltd
NSE:HCLTECH
|
IN |
|
Bausch + Lomb Corp
NYSE:BLCO
|
CA |
|
Isetan Mitsukoshi Holdings Ltd
TSE:3099
|
JP |
|
Balchem Corp
NASDAQ:BCPC
|
US |
|
Spotify Technology SA
NYSE:SPOT
|
LU |
Bankruptcy Probability
Dermata Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Dermata Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Dermata Therapeutics Inc
NASDAQ:DRMA
|
4.8m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
948.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
545.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
222.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
211.4B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
275.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
144.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Dermata Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Dermata Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
